Background Nodal status is a sensitive prognostic indicator in breast cancer. Axillary
metastases may be an indication for neoadjuvant systemic therapy. The aims of this study …

Background The value of axillary staging prior to delivery of neoadjuvant chemotherapy
(NEO) for breast cancer is controversial. Our goal was to analyze the prognostic and …

AIMS: The purpose of this study is to analyse nodal staging and axillary response in breast
cancer patients treated with neoadjuvant chemotherapy (NAC) to explore venues to safely …

Background Optimal evaluation and management of the axilla following neoadjuvant
chemotherapy (NAC) in patients with node-positive breast cancer remains controversial. The …

Background One potential benefit of neoadjuvant therapy (NAT) in node-positive, estrogen
receptor-positive (ER+), human epidermal growth factor receptor 2-negative (HER2−) …

Purpose To retrospectively assess the rate of pathologic complete response in the axilla
according to breast cancer biologic subtypes, and to study the impact of nodal response on …

Background Currently, there are broadly differing patterns in the management of the axilla
after neoadjuvant chemotherapy (NAC) and no consensus with clinically strong evidence on …

Purpose Utilization of sentinel lymph node biopsy (SLNB) in breast cancer patients with
positive nodes after neoadjuvant chemotherapy (NAC) has increased. We examine axillary …

Background Primary aim of our study was to assess the impact of timing of sentinel node
procedure, pre-versus post-neoadjuvant chemotherapy, on final pathologic node-negative …

Background: Axillary node status is used in clinical practice to guide the selection of axillary
surgery in breast cancer patients. However, to date, the optimal axillary management …